Stream 2: Biomarkers & CDx · London

Biomarker Conference London 2027: Meet the Buyers of Your Platform

ImmunoMark London's Biomarkers & Companion Diagnostics stream gathers the pharma and biotech teams who choose assays, platforms and lab partners. Put your team in front of them.

3–4 March 2027
London, UK
400+ target attendees
  • Stream 2 built around biomarker discovery, validation and CDx
  • Pre-booked 20-minute 1:1s chosen from full delegate profiles
  • 70% senior decision-makers at London 2026

Trusted by sponsors from our London 2026 launch edition

Miltenyi Biotec Seer CellCarta BioCytogen Digital Science GemPharmatech Hawk Miltenyi Biotec Seer CellCarta BioCytogen Digital Science GemPharmatech Hawk
Who is in the room

Biomarker conference London: who your team will meet

If you sell assays, multiplex or proteomics platforms, NGS workflows or specialist biomarker lab services, ImmunoMark Summit is the biomarker conference London pharma and biotech teams use to find partners for their oncology programmes.

The 2nd annual UK edition runs on 3–4 March 2027 with a target of 400+ delegates and two parallel streams. Stream 2, Biomarkers & Companion Diagnostics, is where your buyers spend their two days. The prospectus lists the profiles you would expect a biomarker vendor to chase: Heads and Directors of Translational Medicine, Biomarker Operations Leads, Principal Scientists, VPs of Translational Strategy, and teams in Biomarker Discovery & Development, Bioinformatics / Data Science and Companion Diagnostics.

300+attendees at London 2026
100+companies represented in 2026
70%senior decision-makers in 2026
200+meetings conducted in 2026

Companies taking part in 2026 included GSK, Roche, Merck, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb and Incyte, alongside UK biotechs such as ValiRx and Leucid Bio. The 2026 Stream 2 speaker line-up also featured platform and lab-services companies, including Seer, Hologic Diagenode, CellCarta and HAWK Biosystems, so a vendor voice on stage is normal here rather than an exception.

By sector, 55–60% of delegates come from biotech and pharma and 10–15% from academia. By seniority, 45–50% are senior leaders (executives, directors, heads) and 20–30% are scientists, PIs and technologists: the people who sign off a platform and the people who will run it.

Buyer map

A biomarker event London buyers use to evaluate vendors

Different roles judge a biomarker platform on different things. This table maps the main Stream 2 buyer roles to what they evaluate and the London 2027 session where that topic is on stage.

Buyer roleWhat they are evaluatingRelated London 2027 session
Head / Director of Translational MedicineWhether a platform can carry a candidate biomarker from discovery data into a clinical-trial assayDay 1 · The Future of Biomarker-Driven Oncology
Biomarker Operations LeadTurnaround, sample logistics, lab capacity and assay transfer between sitesDay 2 · Multiplex & Programmable Biomarker Platforms
Principal Scientist, biomarker discoveryProteomic and multiplex depth, panel flexibility, sample input requirementsDay 1 · Leveraging Space Genomics to Discover Novel Biomarkers and Identify Emerging Therapeutic Strategies
Biomarker data analytics and bioinformatics leadsData formats, pipelines and how platform output feeds their analysisDay 2 · Real-World Evidence Integration into Biomarker Strategy
Medical diagnostics and CDx leadsWhether an assay can be validated for clinical use and support a diagnostic claimDay 1 · Keynote: Clinical Utility of Biomarkers (AstraZeneca)
Pathology and molecular diagnostics cliniciansTissue requirements and fit with routine pathology workflowsDay 1 · Digital Pathology & Spatial Transcriptomics in Oncology

The 2027 Stream 2 speaker panel includes Matteo Cesaroni, Head of Biomarker Data Analytics at Sanofi, Nitya Nair, Group Head, Translational Biomarker Strategy at Roche, and Espen Walker, Head of Global Medical Diagnostics at AstraZeneca. Expect their peers in the audience to bring the same questions.

1:1 meetings

How a biomarker meeting in London gets booked for your team

Booth traffic is a bonus. For a platform vendor, the pre-scheduled 1:1 programme is the main route to a technical buyer with a live project.

  1. Flag your targets earlyUse the wishlist feature to mark the roles, companies and modalities you want. A proteomics vendor might prioritise biomarker discovery and translational leads; a lab-services company might prioritise biomarker operations.
  2. Review the full delegate listTen days before the event you receive the full delegate list with profiles, and you choose who you want to meet.
  3. Meetings go into your diaryEach meeting is a pre-arranged 20-minute slot. Your team arrives with a schedule, not a hope.
  4. Prepare one page per buyerTwenty minutes is enough for one relevant data set: sample type, plex, turnaround, and a comparable oncology use case.
  5. Use the sessions as warm-upSit in on Multiplex & Programmable Biomarker Platforms or Digital Pathology & Spatial Transcriptomics in Oncology, then continue the conversation at the drinks reception at the end of Day 1.
  6. Follow up with contact detailsEvery package includes the delegate list with contact details, so the follow-up does not depend on a business card.

At London 2026, sponsors averaged 15–25 meetings each and more than 200 meetings took place across the event.

Packages

Which package fits a biomarker platform company

Most platform companies at a biomarker summit in London need meetings first and stage time second. These three packages cover that range.

Best fit

Platinum (Stream 2)

Choose Stream 2 and you get a 30-minute talk on Day 1, the same day as the AstraZeneca and Roche diagnostics sessions, plus a meeting programme large enough to cover several pharma accounts.

  • 10 pre-scheduled 1:1 meetings
  • 30-minute Day 1 talk plus Q&A
  • 10 x 6 ft booth
  • Email to attendees and 1-minute video promotion
  • Attendee list a week before; 8 + 8 passes

Exclusive 1:1 Meetings

For lab-services and assay teams who sell through technical conversations rather than a stand. Pick the volume that matches your sales team.

  • 3, 5, 7 or 10 meetings of 20 minutes
  • 2–4 passes plus drinks reception passes
  • Logo and description in brochure and webpage
  • Wishlist and delegate list

Exhibitor

For instrument and kit companies who need a visible stand for demos across both days, and will work the floor rather than a fixed diary.

  • 10 x 6 ft booth
  • 2 + 2 passes
  • Delegate list and wishlist
  • Website and brochure logo

Gold (6 meetings, 30-minute Day 2 pre-lunch talk) and Silver (15-minute Day 2 post-lunch talk, no pre-scheduled meetings) are also available in Stream 2. Full details are on the London sponsorship opportunities page, and the ROI calculator below lets you test each package against your deal size.

Next steps

Planning for the biomarker conference London 2027 edition

Stream 2 sponsor slots are fixed in the agenda: the Platinum slots run through Day 1, Gold slots sit in the Day 2 morning and the Silver slot opens the Day 2 afternoon. Each package lets you choose your stream, so the earlier you commit, the more choice you have over where your talk lands.

If your platform is aimed at the discovery end of oncology work, such as spatial, single-cell or AI discovery, see our page on the oncology biomarker conference in London for discovery tools. If you build or run assays for companion diagnostics, the companion diagnostics conference London page covers the CDx partnering angle. For a technology-by-technology view across editions, see liquid biopsy, spatial and multiplex platforms at ImmunoMark.

Whether you call it a biomarker congress London teams plan around or a focused two-day summit, the test is the same: the right buyers, booked into your diary.

Tell us your platform and target accounts, and we will suggest the Stream 2 package that fits.

Request the prospectus
Sponsorship ROI calculator

What could London 2027 be worth to your team?

Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.

1. Choose a package

Sponsorship packages
Exclusive 1:1 meeting packages

2. Your numbers

Year-one value of a new pharma or biotech customer

Booth visits, networking and questions after your talk

Share of conversations worth a proposal

Your typical close rate

Sponsorship plus travel and team costs

0x

Estimated return

expected first-year revenue for every £1 of your event budget

Pre-scheduled 1:1 meetings
Qualified conversations
New opportunities
Cost per conversation
Pipeline created
Expected revenue won

Get pricing and the prospectus for this package Or talk to our team about a custom package

Estimates only, based on the numbers you enter. Meetings and inclusions from the London 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.

What sponsors said

Feedback from London 2026 sponsors

Here is what sponsors told us at our London 2026 launch edition.

We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.
PromoCell GmbH logo
Project Manager
PromoCell GmbH · Sponsor, London 2026
We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.
Secretech logo
BD Manager Europe
Secretech · Sponsor, London 2026
Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.
Miltenyi Biotec logo
Research Account Manager
Miltenyi Biotec · Sponsor, London 2026
My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.
Rouken Bio logo
Senior Business Development Director Europe
Rouken Bio · Sponsor, London 2026
We got the occasion to discuss customer projects and understand their needs better and how we can help them.
Hologic Diagenode logo
Epigenomics Applications Specialist
Hologic Diagenode · Sponsor, London 2026
The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.
Hologic Diagenode logo
Biopharma Business Development Manager EMEA
Hologic Diagenode · Sponsor, London 2026
Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.
HistologiX logo
Business Development Executive
HistologiX · Sponsor, London 2026
The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.
HAWK Biosystems logo
Product Specialist
HAWK Biosystems · Sponsor, London 2026

Frequently asked questions

Which stream should a biomarker platform company choose?

Most assay, proteomics, multiplex and NGS vendors choose Stream 2, Biomarkers & Companion Diagnostics, because it covers biomarker discovery, validation, digital pathology, multiplex platforms and CDx. Platinum, Gold and Silver all let you choose your stream. If your platform also serves immune-monitoring work in IO trials, Stream 1 (Next-Gen Immuno-Oncology) is an option.

How are the 1:1 meetings arranged?

Ten days before the event you receive the full delegate list with profiles and choose who you want to meet. The meetings are pre-arranged 20-minute slots. The wishlist feature lets you flag the people and companies you want to reach. Platinum includes 10 meetings, Gold 6 and Headline 15, and the Exclusive 1:1 Meetings package offers 3, 5, 7 or 10.

Can we exhibit without giving a talk?

Yes. The Exhibitor package gives you a 10 x 6 ft booth, 2 team passes plus 2 client passes, the delegate list with contact details, the wishlist feature and your logo on the website and in the brochure. It does not include pre-scheduled meetings. If booked meetings matter more than a stand, the Exclusive 1:1 Meetings package is built for that.

What did sponsors get from London 2026?

London 2026 (5–6 March 2026) had 300+ attendees from 100+ companies, 70% of them senior decision-makers. More than 200 meetings were conducted, sponsors averaged 15–25 meetings each, and title sponsors received 55+ pre-scheduled 1:1 meetings.

How many of our team can come?

Passes depend on the package: Headline includes 10 delegate and 10 client passes, Platinum 8 + 8, Gold 6 + 6, Silver 4 + 4 and Exhibitor 2 + 2. The Exclusive 1:1 Meetings package includes 2–4 passes plus drinks reception passes, and each branding package includes 2 passes.

Sponsor ImmunoMark London 2027

Tell us who you want to meet. We will send the prospectus, current package availability and a recommendation within one working day.